Journal of Virology · 2004 · 19 citations · 20 references
Life SciencesCell BiologyMolecular BiologyMolecular VirologySignal TransductionVirologyHost-virus InteractionsReceptor Tyrosine Kinase SignalingViral InfectionsViral PathogenesisViral TropismVirus-host InteractionsKinase Domain MutationsPoint Mutation EffectsPoint Mutation InductionReceptor Tyrosine Kinase ActivationReceptor Tyrosine Kinase CascadesRetroviral VectorsVirus Vector Host InteractionsVirus-host Receptor Interactions
The erythroleukemia-inducing Friend spleen focus-forming virus (SFFV) encodes a unique envelope protein, gp55, which interacts with the erythropoietin (Epo) receptor complex, causing proliferation and differentiation of erythroid cells in the absence of Epo. Susceptibility to SFFV-induced erythroleukemia is conferred by the Fv-2 gene, which encodes a short form of the receptor tyrosine kinase Stk/Ron (sf-Stk) only in susceptible strains of mice. We recently demonstrated that sf-Stk becomes activated by forming a strong interaction with SFFV gp55. To examine the biological consequences of activated sf-Stk on erythroid cell growth, we prepared retroviral vectors which express sf-Stk, either in conjunction with gp55 or alone in a constitutively activated mutant form, and tested them for their ability to induce Epo-independent erythroid colonies ex vivo and disease in mice. Our data indicate that both gp55-activated sf-Stk and the constitutively activated mutant of sf-Stk induce erythroid cells from Fv-2-susceptible and Fv-2-resistant (sf-Stk null) mice to form Epo-independent colonies. Mutational analysis of sf-Stk indicated that a functional kinase domain and 8 of its 12 tyrosine residues are required for the induction of Epo-independent colonies. Further studies demonstrated that coexpression of SFFV gp55 with sf-Stk significantly extends the half-life of the kinase. When injected into Fv-2-resistant mice, neither the gp55-activated sf-Stk nor the constitutively activated mutant caused erythroleukemia. Surprisingly, both Fv-2-susceptible and -resistant mice injected with the gp55-sf-Stk vector developed clinical signs not previously associated with SFFV-induced disease. We conclude that sf-Stk, activated by either point mutation or interaction with SFFV gp55, is sufficient to induce Epo-independent erythroid colonies from both Fv-2-susceptible and -resistant mice but is unable to cause erythroleukemia in Fv-2-resistant mice.
20
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Maria Flavia Di Renzo, Martina Olivero, S. Ferro et al. · PubMed · 1992 · 318 citations
Medicine, Endocrinology, Oncology +14
A Yoshimura, Alan D. D’Andrea, H F Lodish · Proceedings of the National Academy of Sciences · 1990 · 237 citations